HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
Khan O, Fotheringham S, Wood V, Stimson L, Zhang C, Pezzella F, Duvic M, Kerr DJ, La Thangue NB.
Khan O, et al. Among authors: la thangue nb.
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6532-7. doi: 10.1073/pnas.0913912107. Epub 2010 Mar 22.
Proc Natl Acad Sci U S A. 2010.
PMID: 20308564
Free PMC article.